TY - JOUR
T1 - Follow-up after molar pregnancy evacuation
T2 - Feasibility of using semi-quantitative urine pregnancy tests
AU - Hoppenot, Claire
AU - Zimmerman, Lindsay
AU - Arlandson, Mary
AU - Lurain III, John Robert
AU - Patel, Ashlesha
N1 - Publisher Copyright:
© Journal of Reproductive Medicine®, Inc.
PY - 2016/6/1
Y1 - 2016/6/1
N2 - OBJECTIVE: To evaluate human chorionic gonadotropin (hCG) trends after evacuation of complete hydatidiform moles to determine if urinary semiquantitative pregnancy tests (SQPTs) could replace blood draws while still detecting early postmolar gestational trophoblastic neoplasia. STUDY DESIGN: A retrospective review of complete hydatidiform moles at a safety-net hospital from 2003-2013 was performed. hCG curves were used to extrapolate expected SQPT results over time for a resolving hydatidiform mole. RESULTS: Of 61 complete moles, 37 had an uncomplicated hCG decline and at least 4 serum hCG results. All of those patients had hCG <10,000 mIU/mL within 15 days, <2,000 within 64 days, <500 within 70 days (92.2% within 1 month), <100 within 89 days (90% within 2 months), and <25 within 152 days (95.2% within 3 months). After reaching levels <25, hCG rose only in cases of new pregnancies. CONCLUSION: Based on this retrospective analysis, SQPT monitoring could have avoided 90% of blood draws while still flagging all patients with subsequent postmolar GTN within 45 days by limiting blood draws to (1) patients with SQPT levels of >10,000, >500, and >100 mIU/mL at 15, 30, and 45 days, respectively, (2) hCG >25 after 60 days, or (3) increasing SQPT levels.
AB - OBJECTIVE: To evaluate human chorionic gonadotropin (hCG) trends after evacuation of complete hydatidiform moles to determine if urinary semiquantitative pregnancy tests (SQPTs) could replace blood draws while still detecting early postmolar gestational trophoblastic neoplasia. STUDY DESIGN: A retrospective review of complete hydatidiform moles at a safety-net hospital from 2003-2013 was performed. hCG curves were used to extrapolate expected SQPT results over time for a resolving hydatidiform mole. RESULTS: Of 61 complete moles, 37 had an uncomplicated hCG decline and at least 4 serum hCG results. All of those patients had hCG <10,000 mIU/mL within 15 days, <2,000 within 64 days, <500 within 70 days (92.2% within 1 month), <100 within 89 days (90% within 2 months), and <25 within 152 days (95.2% within 3 months). After reaching levels <25, hCG rose only in cases of new pregnancies. CONCLUSION: Based on this retrospective analysis, SQPT monitoring could have avoided 90% of blood draws while still flagging all patients with subsequent postmolar GTN within 45 days by limiting blood draws to (1) patients with SQPT levels of >10,000, >500, and >100 mIU/mL at 15, 30, and 45 days, respectively, (2) hCG >25 after 60 days, or (3) increasing SQPT levels.
KW - Choriocarcinoma
KW - Chorionic gonadotropin
KW - Gestational trophoblastic disease
KW - Gestational trophoblastic neoplasia
KW - Hydatidiform mole
KW - Pregnancy tests
KW - Uterine neoplasms
UR - http://www.scopus.com/inward/record.url?scp=84969718514&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84969718514&partnerID=8YFLogxK
M3 - Article
C2 - 27424357
AN - SCOPUS:84969718514
SN - 0024-7758
VL - 61
SP - 192
EP - 196
JO - Journal of Reproductive Medicine
JF - Journal of Reproductive Medicine
IS - 3
ER -